Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 231-234

  Polanco, Natalia ^a   Gutiérrez, Elena ^a   Rivera, Francisco ^b   Castellanos, Ines ^c   Baltar, José ^d   Lorenzo, Dolores ^e   Praga, Manuel ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^c HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; TREATMENT DURATION;

AGED; CREATININE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROGNOSIS; REMISSION, SPONTANEOUS;

EID: 84856641796     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr285     Document Type: Article

References (14)

1. Donadio JJV, Torres VE, Velosa JA et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988; 33: 708-715 (Pubitemid 18083120)
2. Glassock RJ. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum? Am J Kidney Dis 2004; 44: 562-566 (Pubitemid 39164634)
3. Cattran DC. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol 2005; 16: 1188-1194
4. du Buf-Vereijken PWG, Branten AJW, Wetzels JFM. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis 2005; 46: 1012-1029 (Pubitemid 41690227)
5. Fervenza F, Sethi S, Specks U. Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 2008; 3: 905-919
6. Polanco N, Gutiérrez E, Covarśi A et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 2010; 21: 697-704
7. Beck LH Jr, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21
8. Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053-2060 (Pubitemid 34680597)
9. Prunotto M, Carnevali ML, Candiano G et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 2010; 21: 507-519
10. Branten AJW, Vervoort G, Wetzels JFM. Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant 2005; 20: 707-711 (Pubitemid 40520646)
11. Troyanov S, Wall CA, Miller JA et al. Idiopathic membranous nephr-opathy: definition and relevance of a partial remission. Kidney Int 2004; 66: 1199-1205 (Pubitemid 39121029)
12. Medhi UF, Adams-Huet B, Raskin P et al. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angio-tensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol 2009; 20: 2641-2650
13. Torres A, Domínguez-Gil B, Carreño A et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney Int 2002; 61: 219-227 (Pubitemid 34075150)
14. Troyanov S, Roasio L, Pandes M et al. Renal pathology in idiopathic membranous nephropathy: a new perspective. Kidney Int 2006; 69: 1641-1648